Ridgewood Investments LLC Abb Vie Inc. Transaction History

Ridgewood Investments LLC

$201 Million
Q3 2024

A detailed history of Ridgewood Investments LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ridgewood Investments LLC holds 65 shares of ABBV stock, worth $11,700. This represents 0.01% of its overall portfolio holdings.

Number of Shares

Previous 157 58.6%

Holding current value

$11,700

Previous $26,000 53.85%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$163.84 - $199.33 $15,073 - $18,338	-92 Reduced 58.6%	65 $12,000
Q2 2024 Jul 29, 2024	BUY	$154.79 - $180.76 $24,302 - $28,379	157 New	157 $26,000
Q2 2023 Aug 07, 2023	BUY	$132.51 - $164.9 $132 - $164	1 Added 0.08%	1,200 $161,000
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $22,414 - $25,813	-155 Reduced 11.45%	1,199 $191,000
Q4 2022 Jan 19, 2023	BUY	$138.31 - $165.87 $187,271 - $224,587	1,354 New	1,354 $0
Q1 2022 Apr 11, 2022	SELL	$131.98 - $163.75 $1.39 Million - $1.72 Million	-10,533 Reduced 87.64%	1,486 $241,000
Q3 2021 Oct 20, 2021	BUY	$106.4 - $120.78 $118,104 - $134,065	1,110 Added 10.18%	12,019 $1.3 Million
Q2 2021 Jul 22, 2021	SELL	$105.21 - $117.21 $45,240 - $50,400	-430 Reduced 3.79%	10,909 $1.23 Million
Q1 2021 Apr 27, 2021	BUY	$102.3 - $112.62 $50,536 - $55,634	494 Added 4.56%	11,339 $1.23 Million
Q3 2020 Oct 14, 2020	BUY	$85.91 - $100.83 $106,872 - $125,432	1,244 Added 12.96%	10,845 $950,000
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $73,149 - $97,885	997 Added 11.59%	9,601 $943,000
Q1 2020 Apr 27, 2020	SELL	$64.5 - $97.79 $2,902 - $4,400	-45 Reduced 0.52%	8,604 $656,000
Q4 2019 Jan 15, 2020	BUY	$72.13 - $90.25 $288 - $361	4 Added 0.05%	8,649 $766,000
Q3 2019 Oct 23, 2019	SELL	$62.98 - $75.72 $2,456 - $2,953	-39 Reduced 0.45%	8,645 $655,000
Q2 2019 Jul 12, 2019	BUY	$65.7 - $83.98 $130,348 - $166,616	1,984 Added 29.61%	8,684 $631,000
Q1 2019 Apr 15, 2019	BUY	$77.14 - $90.79 $516,838 - $608,293	6,700 New	6,700 $540,000
Q1 2018 Apr 17, 2018	SELL	$92.01 - $123.21 $377,609 - $505,653	-4,104 Closed	0 $0
Q4 2017 Jan 12, 2018	SELL	$89.56 - $98.21 $806 - $883	-9 Reduced 0.22%	4,104 $397,000
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $287,293 - $366,961	4,113	4,113 $365,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ridgewood Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ridgewood Investments LLC with notifications on news.

Account

Ridgewood Investments LLC Abb Vie Inc. Transaction History